Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06225414 · ClinicalTrials.gov registry record · NA
Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)
A NA study of Lung Cancer, sponsored by University of California, Irvine.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 10
- Study locations
NCT06225414: Active NA study of Lung Cancer, sponsored by University of California, Irvine.
NCT06225414 is a NA study of Lung Cancer that is active but no longer recruiting, run by University of California, Irvine. The registered enrollment target is 60 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower). The trial reports 10 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06225414, a NA study of Lung Cancer, is active but no longer recruiting, sponsored by University of California, Irvine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 10
- Study locations
Study Summary
The Hispanic/Latinx community (hereafter Hispanic) is the country's second-largest racial/ethnic group, accounting for 19.1% of the total population. However, they remain one of the most underserved populations with suboptimal access to healthcare and screening services due to low income, lack of health insurance, perceived discrimination, language barriers, and limited health literacy. Lung cancer is the leading cause of cancer related mortality with 1.8 million annual deaths worldwide, with Hispanic patients known to have lower survival rates compared with non-Hispanic whites. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases this mortality rate of lung cancer by 20%. Yet many Latinx patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test and compare the effect of a multi-level intervention on ordering LDCT within 4 months after patient enrollment to those in an Enhanced Usual Care. Our proposed intervention includes: * Primary care provider notifications of patients' LCS eligibility; * Patients' education; * Patients' referral to financial navigation resources; * Patients' reminder to discuss LCS during primary care provider (PCP) visit.
Conditions Studied
Interventions
- OTHER Usual Care
- BEHAVIORAL Patient education
- BEHAVIORAL Brief Patient Education
- BEHAVIORAL Referral to financial navigation resources
- BEHAVIORAL Patient Reminders
Study Locations (10)
California
- UCI Health Family Health Center - Anaheim - Anaheim
- UCI Health-Costa Mesa - Costa Mesa
- UCI Health-Irvine - Irvine
- UCI Health-Laguna hilla - Laguna Hills
- UCI Health-Newport - Newport Beach
- UCI Health SeniorHealth Center -Pavillion 4 - Orange
- UCI Medical Center, Pavilion 3 - Orange
- UCI Health Family Health Center - Santa Ana - Santa Ana
- UCI-Health Tustin - Tustin
- UCI Health-Yorba Linda - Yorba Linda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-02-12 |
| Est. Completion | 2026-02 |
| Phase | NA |
What the registry record for NCT06225414 still lists
NCT06225414 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 5 interventions - of which Usual Care is the first listed.
NCT06225414 lists 10 locations in 1 state (California).
Frequently Asked Questions
What is clinical trial NCT06225414 about?
NCT06225414 is a clinical study titled "Empowering Hispanic Patients' Lung Cancer Screening Uptake (Empower Latinx)". The Hispanic/Latinx community (hereafter Hispanic) is the country's second-largest racial/ethnic group, accounting for 19.1% of the total population. However, they remain one of the most underserved populations with suboptimal access to healthcare and screening services due to low income, lack of he...
What is the current status of trial NCT06225414?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-02-12. Estimated completion is 2026-02.
What conditions does trial NCT06225414 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT06225414?
The interventions under investigation include: Usual Care (OTHER), Patient education (BEHAVIORAL), Brief Patient Education (BEHAVIORAL), Referral to financial navigation resources (BEHAVIORAL), Patient Reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT06225414?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06225414 being conducted?
This trial has 10 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06225414's enrollment target sits among peer trials
60 244th of 409 higher than 159 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI